Stanford University Medical Center
Stanford Study of Malaria Vaccine Needs Participants
Published in Vaccine Weekly, May 6th, 2009
The phase-1 clinical trial, which is under way at both Stanford and Vanderbilt University in Nashville, Tenn., aims to test the safety of and immune response to different doses of the vaccine in a total of 72 healthy adults. It is funded by the National Institutes of Health.
Results from this study will allow a second trial to begin in Africa this year.
“This a chance for those who know that malaria causes millions of deaths every year to step forward and help in the search for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-05-06)
More Articles from Vaccine Weekly
- Antivirals
Research results from S.F. Emonet and colleagues update understanding of antivirals - Cancer Vaccines
Newly published study shows that re-treatment with Pegasys® (peginterferon alfa-2a) provides hepatitis C patients with a second chance for a cure - Colon Cancer
Research conducted at Charite University has updated our knowledge about colon cancer - Herpesvirus
Data from P.D. Burbelo and colleagues advance knowledge in herpesvirus - Immunization
Investigators at Merck & Company, Inc. publish new data on immunization - Immunization
New immunization findings from M. Humar and co-authors described - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
